Case Details
- Citation: [2016] SGHCR 5
- Title: Cordlife Group Limited v Cryoviva Singapore Pte Ltd
- Court: High Court (Registrar)
- Case Type: Assessment of Damages (pursuant to Consent Order)
- Suit No: 91 of 2014
- Assessment No: AD 15 of 2015
- Date of Judgment: 15 April 2016
- Judge: Nicholas Poon AR
- Hearing Dates: 19, 20, 21 October 2015; 27 November 2015; 9 December 2015
- Plaintiff/Applicant: Cordlife Group Limited
- Defendant/Respondent: Cryoviva Singapore Pte Ltd
- Legal Areas: Intellectual Property (Trade Marks, Copyright, Passing Off); Damages Assessment
- Statutes Referenced: Copyright Act (Cap 63, 2006 Rev Ed) (including ss 119(3) and 119(4)); and reference to “The Plaintiff came to know of the Act” (as reflected in the metadata extract)
- Cases Cited: [2004] SGHC 76; [2005] SGHC 183; [2014] SGHCR 11; [2015] SGHCR 15; [2016] SGHCR 5
- Judgment Length: 54 pages; 13,413 words
Summary
Cordlife Group Limited v Cryoviva Singapore Pte Ltd concerned the assessment of damages following a Consent Order entered on 24 January 2014. The underlying liability had already been agreed: the Defendant was ordered to pay damages for trade mark infringement, copyright infringement, and passing off arising from the content and “getup” of the Defendant’s websites. The present decision, delivered by Nicholas Poon AR, addressed the remaining issues left open by the Consent Order—namely the extent of infringement and the quantum of damages.
After considering the evidence and submissions, the Registrar awarded damages of $63,904.63 to the Plaintiff. Although the Plaintiff had sought at least $543,375.63, the court found that key heads of loss—particularly loss of business reputation and goodwill, and loss of profit—were not sufficiently substantiated or causally linked to the infringements and passing off. The court also rejected the Plaintiff’s higher claims for additional and exemplary damages under the Copyright Act, while addressing the Defendant’s arguments regarding the appropriate measure of copyright damages and the effect of alleged “innocence” in the infringement.
What Were the Facts of This Case?
The Plaintiff, Cordlife Group Limited, operates a private cord blood bank in Singapore. It was incorporated on 2 May 2001 and began operations in 2002. Cordlife was listed on the mainboard of the Singapore Exchange Securities Trading Limited on 29 March 2012. The Defendant, Cryoviva Singapore Pte Ltd, was incorporated on 26 July 2013 with the intention of entering the private cord blood banking business in Singapore. At the relevant time, Cordlife’s CEO was Mr Jeremy Yee and its CFO was Ms Thet Hnin Yi, while Cryoviva’s CEO was Dr Ashish Munjal.
The dispute arose from the Defendant’s website content. In preparation for its launch, Cryoviva engaged a third-party vendor, Maverick Innovations Pvt Ltd (“Maverick”), to design and create a website. Between late August 2013 and October 2013 (the exact timing was disputed), Cryoviva’s “Trial website” went live at http://www.cryoviva.com.sg/trial/. This Trial website was intended to be a mock-up of the Defendant’s final website. The “Actual website” later went live on or around 27 December 2013 at http://www.cryoviva.com.sg/.
Cordlife became aware of the Actual website around 30 December 2013, and it also learned of the Trial website thereafter. Cordlife’s case was that, by 14 January 2014, after its staff reviewed the Trial and Actual websites, it was clear that Cryoviva had used Cordlife’s proprietary information and intellectual property without knowledge or consent. Cordlife’s allegations were threefold: first, that the Trial website infringed Cordlife’s registered trade marks bearing the name “Cordlife”; second, that both the Trial and Actual websites infringed Cordlife’s copyright by reproducing electronic forms, content, and “getup” from Cordlife’s website at http://www.cordlife.com/sg/en; and third, that by using Cordlife’s trade mark and replicating its website getup, Cryoviva passed off as being related to or associated with Cordlife.
On 20 January 2014, Cordlife’s solicitors wrote to Cryoviva demanding, among other things, that Cryoviva cease operation of the Trial and Actual websites. On 22 January 2014, Cordlife applied for an interim injunction to restrain Cryoviva from reinstating the Trial website and operating the Actual website. However, the parties settled quickly. On 24 January 2014, a Consent Order was entered. Under that Consent Order, Cryoviva agreed to pay damages for (i) trade mark infringement by virtue of the Trial website, (ii) copyright infringement by virtue of the Trial and Actual websites, and (iii) passing off by virtue of the Trial and Actual websites. The Consent Order further provided that the extent of infringement and the quantum of damages would be decided by the court if not agreed. As part of the settlement, Cryoviva also published a public apology in major local newspapers on 27 and 28 February 2014 acknowledging that it had infringed Cordlife’s intellectual property rights through Trial and Actual websites containing material and features copied from and/or similar to Cordlife’s website.
Because the parties could not agree on the extent of infringement and the quantum of damages, Cordlife commenced the present assessment action on 7 May 2014. Cordlife sought damages of at least $543,375.63 across four categories: general damages for loss of profit and loss of business reputation and goodwill; special damages for investigation costs; additional damages under s 119(4) of the Copyright Act; and exemplary damages. Cryoviva resisted, arguing that Cordlife’s claimed losses were unsubstantiated and not causally attributable to the infringements and passing off. For copyright, Cryoviva further argued that the appropriate measure should be a licence fee rather than damages, and that the Plaintiff was not entitled to damages but at best an account of profits because the infringements were innocently committed under s 119(3) of the Copyright Act.
What Were the Key Legal Issues?
The Registrar framed the issues in three parts. First (“Issue 1”), the court had to determine whether Cordlife had proved its losses—loss of profit, loss of business reputation and goodwill, and investigation costs—and, if so, whether those losses were attributable to the Defendant’s infringements and passing off. This required both proof of loss and proof of causation.
Second (“Issue 2”), the court had to address the proper measure of relief for copyright infringement. Specifically, it had to consider whether the Defendant’s liability should be limited to paying a licence fee, and whether the infringements were “innocent” such that, under s 119(3) of the Copyright Act, Cordlife’s remedy should be an account of profits rather than damages.
Third (“Issue 3”), the court had to decide whether the character of the infringements, together with the Defendant’s conduct, warranted additional damages under s 119(4) of the Copyright Act and whether exemplary damages should be awarded.
How Did the Court Analyse the Issues?
Issue 1: proof of loss and causation
The Registrar approached Issue 1 by separating it into two questions: whether Cordlife had suffered the claimed losses, and whether there was evidence that the infringements and passing off caused those losses. The analysis began with the head of loss relating to business reputation and goodwill. Cordlife’s counsel relied on four factors: (a) an alleged disparity in quality between Cordlife’s and Cryoviva’s products and services; (b) Cordlife’s substantial investment in facilities to attain accreditation standards; (c) Cordlife’s significant advertising and promotion spend; and (d) the alleged greater reputational impact because the infringements occurred on the internet, which has wide reach.
The Registrar accepted that the internet can amplify reputational harm, but held that Cordlife still had to prove the loss with objective evidence. The court agreed with Cryoviva that Cordlife had not proven this head of loss. The Registrar emphasised that the factors relied upon did not objectively show that Cordlife had suffered a loss of business reputation and goodwill. In particular, the court found no evidence of a disparity in quality between the parties’ respective services. The Registrar also considered the relevance of the legal distinction between damages for loss of reputation and goodwill in passing off/trade mark infringement, and damages based on differences in quality. Relying on Mopi Pte Ltd v Central Mercantile Corp (S) Ltd ([2005] SGHC 183), the Registrar noted that damages for loss of reputation are not synonymous with damages for differences in quality; “surer evidence” is required of the nature of the alleged inferiority and how it translates into monetary loss.
Further, the Registrar gave limited weight to affidavit evidence that Cordlife’s reputation had been “severely impacted” and that it had lost potential customers because they associated Cordlife with Cryoviva. The court characterised these as bare assertions and speculative statements without objective proof. This evidential approach reflects a consistent theme in damages assessment: even where infringement is established, the claimant must still demonstrate the extent of loss and the causal link to the infringement, rather than rely on generalised assumptions about harm.
Issue 2: copyright damages, licence fee, and “innocence”
On the copyright claims, Cryoviva advanced two broad submissions. First, it argued that the appropriate response should be damages representing the cost of obtaining a licence for the copyrighted works. However, the Registrar noted that this approach required proper pleading and evidence to establish the substantiality of any licence fee. The Defendant’s position was therefore constrained by the evidential record.
Second, Cryoviva relied on s 119(3) of the Copyright Act, submitting that because the infringements were innocently committed, Cordlife was not entitled to damages but, at best, to an account of profits. Cryoviva’s “innocence” argument was premised on the fact that Maverick had reproduced the information from Cordlife’s website without Cryoviva’s knowledge, and that Cryoviva was not aware, and had no reasonable grounds for suspecting, that Maverick had committed the infringements. The Registrar had to evaluate whether the statutory conditions for limiting relief were satisfied on the evidence.
Although the excerpt provided does not reproduce the full reasoning on this point, the ultimate award of damages at a level far below Cordlife’s claim indicates that the court did not accept Cordlife’s higher damages theory and also did not accept that the Defendant’s liability should be entirely neutralised. The court’s award suggests a careful calibration: it recognised infringement and the need to compensate, but it did not accept that the Plaintiff had proven the magnitude of loss or that the statutory framework required a different remedy in the manner urged by the Defendant.
Issue 3: additional and exemplary damages
Cordlife sought additional damages under s 119(4) of the Copyright Act, arguing that the infringements were “flagrant” and persisted even after the Consent Order. It also sought exemplary damages, contending that the flagrancy of the infringements and the Defendant’s conduct justified a further award.
Cryoviva rejected these claims, reiterating that the infringements were innocently caused by Maverick and that once Cryoviva found out, it took immediate steps to rectify the situation and address Cordlife’s concerns. The Registrar’s approach to Issue 3 would have required an assessment of the seriousness of the infringement, the Defendant’s conduct, and whether the statutory threshold for additional damages was met. The final award—again, significantly lower than the amount claimed—indicates that the court did not find sufficient basis to impose substantial additional or exemplary damages on the facts as proved.
What Was the Outcome?
The Registrar awarded Cordlife $63,904.63 in damages. This figure was substantially lower than the Plaintiff’s pleaded claim of at least $543,375.63, reflecting the court’s conclusion that key heads of loss were not adequately substantiated and/or not proven to be causally attributable to the infringements and passing off.
Practically, the decision underscores that even where liability for IP infringement and passing off is established by consent, the assessment phase remains a rigorous evidential exercise. The court’s award suggests that only those components of loss that were properly evidenced and linked to the infringement were recoverable, while claims for broader reputational and profit losses, as well as additional and exemplary damages, were not made out on the evidence presented.
Why Does This Case Matter?
This case is significant for practitioners because it illustrates how Singapore courts approach damages assessment in IP disputes involving websites and online “getup”. The decision demonstrates that the existence of infringement does not automatically translate into large damages for reputation or lost profits. Claimants must provide objective evidence of loss and a credible causal connection between the infringement and the claimed monetary harm.
From a copyright remedies perspective, the case is also instructive on the interaction between damages and the statutory alternatives in s 119 of the Copyright Act. Defendants may attempt to invoke s 119(3) to argue for an account of profits where infringement is “innocently” committed, while plaintiffs may seek additional damages under s 119(4) where infringement is flagrant. The outcome here shows that these statutory pathways are fact-sensitive and evidence-dependent: arguments about innocence, licence fees, and flagrancy must be supported by proper pleading and proof.
Finally, the decision serves as a cautionary tale for settlement-driven litigation. Consent orders can resolve liability but leave open the extent of infringement and quantum. Parties should therefore treat the assessment stage as a full evidential hearing, ensuring that claims for loss of goodwill, profit, and additional/exemplary damages are supported by concrete documentation, not merely assertions or generalised inferences.
Legislation Referenced
Cases Cited
- [2004] SGHC 76
- [2005] SGHC 183
- [2014] SGHCR 11
- [2015] SGHCR 15
- [2016] SGHCR 5
- Mopi Pte Ltd v Central Mercantile Corp (S) Ltd ([2005] SGHC 183)
Source Documents
This article analyses [2016] SGHCR 5 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.